Rodney K. Edwards et al [6] Boudreaux MC, Miller JM Jr, Wightkin J, Martin S, Mather F. Collaborative care for obstetric patients at low and high Risk: an evolving model. Journal of Perinatology. 1997;17(1):33–36. [7] Miller JM Jr, Maupin RT, Mestad RE, Nsuami M. Initial and repeated screening for gonorrhea during pregnancy. Sexually Transmitted Diseases. 2003;30(9):728–730. [8] Christmas JT, Wendel GD, Bawdon RE, Farris R, Cartwright G, Little BB. Concomitant infection with Neisseria gonorrhoeae and Chlamydia trachomatis in pregnancy. Obstetrics and Gy- necology. 1989;74(3 I):295–298. [9] Centers for Disease Control Prevention. Sexually transmitted disease surveillance 2003 supplement. Atlanta, Ga: Department of Health and Human Services, Centers for Disease Control and Prevention; December 2004. syphilis surveillance report. [10] Magriples U, Copel JA. Can risk factor assessment replace uni- versal screening for gonorrhea and Chlamydia in the third trimester? American Journal of Perinatology. 2001;18(8):465– 468. [11] Schrag SJ, Arnold KE, Mohle-Boetani JC, et al. Prenatal screening for infectious diseases and opportunities for preven- tion. Obstetrics and Gynecology. 2003;102(4):753–760. 3